Globus Medical Inc. Class A Common Stock vs Kingsoft Cloud Holdings Limited — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Kingsoft Cloud Holdings Limited trades at $8.58 (market cap $2.77B). The key difference: Globus Medical Inc. Class A Common Stock is far larger — about 3.7× Kingsoft Cloud Holdings Limited's market cap, and Globus Medical Inc. Class A Common Stock is trading nearer its 52-week high, Kingsoft Cloud Holdings Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Kingsoft Cloud Holdings Limited for 12 Days on average.
| GMED | KC | |
|---|---|---|
Market Cap | $10.25B | $2.77B |
Volume | 1,108,124 | 986,009 |
Sector | Health | Technology |
52-Week High | $96.82 | $18.21 |
52-Week Low | $58.33 | $8.58 |
Typical Hold Time | 0 Days | 12 Days |
Enterprise Value | $9.76B | $3.10B |
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Kingsoft Cloud (KC) trades at $9.32, up 0.76% with a bearish technical signal despite recent earnings beats. The company shows improving revenue trends ($11.0B projected for 2026) and significant AI cloud growth, though profitability remains negative with -5.46% net margin. Analyst sentiment is strongly positive with 70% buy ratings and 60.25% upside potential cited.
KC presents a high-risk, high-reward opportunity with strong AI-driven growth potential but persistent profitability challenges. The stock's appeal hinges on continued AI cloud expansion and margin improvement, though investors face execution risks and Chinese regulatory exposure. Wall Street optimism contrasts with current technical weakness.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →Kingsoft Cloud is a leading independent cloud service provider in China. It offers a comprehensive suite of cloud products and solutions tailored for industries like gaming, video streaming, and financial services.
Read more on KC →